Close Menu

GeneProt Lays Off Almost Half Its Staff

As ProteoMonitor went to press, news broke that GeneProt of Geneva, Switzerland, is undergoing a major reorganization. The company will lay off 45 of its 95 employees, starting in less than two weeks, according to CSO Keith Rose. Last fall, the company already underwent a round of layoffs that took effect in January (see ProteoMonitor 11-4-02).


OGS Shareholders Reject Celltech Offer; More Bids from Biotech Investors Expected

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.